Asia · Regional markets · CNBC-TV18

Dr Reddy’s Q2 Results: Net profit falls as lower Lenalidomide sales hit revenue; beats estimates

Published by CNBC-TV18 · India 1 h ago

Dr Reddy’s Laboratories reported a 36% YoY decline in Q2 FY27 net profit to ₹913.4 crore, while revenue fell 1.5% to ₹8,671 crore. The company beat CNBC-TV18 poll estimates for…

Read the full article on CNBC-TV18 Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.cnbctv18.com)

Also worth reading

The Straits Times Business

Amex to Slash 5% of Headcount as CEO Seeks to Reduce Expenses

The Business Times

Net demand for Singapore office space doubles in Q3 as central region rents rise 0.8%

Tech in Asia

Dr Reddy’s Q2 Results: Net profit falls as lower Lenalidomide sales hit revenue; beats estimates

Share

Also worth reading

Amex to Slash 5% of Headcount as CEO Seeks to Reduce Expenses

Net demand for Singapore office space doubles in Q3 as central region rents rise 0.8%

Self-driving delivery in Malaysia? Not yet, but Neolix is ready

FSS eyes sanctions for Mirae Asset over SpaceX share cancellation

C-Wave music program reaches 2 billion streams in Malaysia finals

PM orders urgent measures to strengthen energy security through 2030